Eli Lilly and Company (LLY · NYSE)
LLY · MARKET VIEW
Market view · as of Jul 13, 2026
Revenue (TTM)
$72.25B
+55.5% YoY
Gross margin
82.8%
EPS (latest q)
$8.55
vs $6.79 est · beat
52-wk position
92.4%
-3.8% vs 52w high · +4.6% 1mo
Price (last ~year)
Eli Lilly and Company (LLY) recorded 55.5% year-over-year revenue growth and a 169.9% increase in earnings, reaching $72.25 billion in trailing twelve-month revenue. The company maintains an operating margin of 49.4% and reported $7.40 billion in net income for the quarter ending March 31, 2026. With a market capitalization of $1.06 trillion, the stock is trading at $1188.58, reflecting a 29.1% gain over the last three months.
Valuation
- Market cap
- $1.06T
- P/E
- 42.19
- PEG
- 1.537
- P/B
- 33.97
- P/S
- 14.67
- EV/EBITDA
- 30.32
- Beta
- 0.506
- Analyst target
- $1240.46
Quality & returns
- Gross margin
- 82.8%
- Operating margin
- 49.4%
- Profit margin
- 35.0%
- ROE
- 107.5%
- ROA
- 20.7%
Price movement
- Last
- $1188.58
- 1-month
- +4.6%
- 3-month
- +29.1%
- RSI (14)
- 66
- vs SMA200
- +19.6%
- 52-wk position
- 92.4% -3.8% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $19.80B | $8.85B | $7.40B | $9.69B |
| 2025-12-31 | $19.29B | $8.78B | $6.64B | $8.39B |
| 2025-09-30 | $17.60B | $8.39B | $5.58B | $7.88B |
| 2025-06-30 | $15.56B | $7.13B | $5.66B | $7.50B |
Recent news
- Somewhat-Bullish Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)? · 2026-07-12
- Somewhat-Bullish Which is the Better Choice for Healthcare Investors? IYH or BBH? · 2026-07-11
- Somewhat-Bullish Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)? · 2026-07-11
- Somewhat-Bullish Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)? · 2026-07-11
- Somewhat-Bullish Conning Inc. Has $33.85 Million Position in Amgen Inc. $AMGN · 2026-07-11
- Bullish Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Eli Lilly & Co (LLY) · 2026-07-11
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)